MYAML

WIPO WIPO 2014

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke MYAML wurde als Wortmarke am 05.06.2014 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 20. Oktober 2022

Markenform Wortmarke
Aktenzeichen 1252448
Länder Schweiz China Europäische Gemeinschaft Japan Südkorea
Basismarke US Nr. 86141237, 11. Dezember 2013
Anmeldedatum 05. Juni 2014
Ablaufdatum 05. Juni 2024

Markeninhaber

10222 Barnes Canyon Road,
Building 1
US

Markenvertreter

Level 43, Bourke Place, 600 Bourke Street AU

Waren und Dienstleistungen

01 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
05 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
21. März 2018 2018/21 Gaz US RAW: Partial Ceasing Effect
12. Dezember 2016 2017/11 Gaz CH Ablehnung
27. Juni 2016 2016/27 Gaz KR Ablehnung
16. Juni 2016 2016/27 Gaz CH Ablehnung
27. April 2016 2016/20 Gaz EM Ablehnung
11. April 2016 2016/19 Gaz CN Ablehnung
12. Januar 2016 2016/3 Gaz KR Ablehnung
26. November 2015 2015/48 Gaz JP Ablehnung
05. Juni 2014 2015/24 Gaz US Eintragung

ID: 141252448